Company
Polarean Imaging PLC
LON:POLX
Polarean Imaging PLC and its wholly owned subsidiary, Polarean Inc., are revenue-generating, medical imaging technology companies operating in the high-resolution medical imaging space. Polarean aspires to revolutionize pulmonary medicine by bringing the power and safety of MRI to the respiratory healthcare community in need of new solutions to evaluate lung function, diagnose disease, characterize disease progression, and monitor response to treatment.
177 stories · page 4 of 9
Polarean Imaging updates on FDA review
The company has developed a drug-device system that provides enhanced imagery of the lungs using hyperpolarised xenon-129 gas
Polarean Imaging says US FDA requests additional information from manufacturing partner of its xenon-129 gas blend drug
The company said this request is related to the recent cGMP (Current Good Manufacturing Practice) pre-approval inspection at the partner's production facility
Polarean Imaging appoints Dr Marcella Ruddy as non-executive director
Ruddy has over 15 years of experience in the development of respiratory and other therapeutic compounds across all stages of clinical development
Polarean Imaging completes system installation at Cincinnati Children's Hospital Medical Center
“CCHMC runs an exceptional programme for advancing non-invasive hyperpolarised noble gas MR imaging in paediatric research and we are thrilled that we can support them in their endeavours."